In response to the rapidly developing Corona virus outbreak, the IRS has issued guidance confirming that COVID-19 testing and treatment will be considered preventive care under high deductible health plans (HDHPs). Under Notice 2020-15 the IRS confirmed that any HSA-qualified HDHP can pay for COVID-19 testing and treatment before the annual deductible is satisfied and still maintain its status as an HSA-qualified plan. The IRS issued this Notice to help remove financial barriers to COVID-19 testing and treatment.
For your reference we have attached a copy of IRS Notice 2020-15, which was issued on March 11, 2020 and is valid until any further guidance is issued.
Steve Chase is Senior Vice President of BPAS Healthcare Consulting Services.